32 Recruiting Cancer Phase 2 Clinical Trials
Active phase 2 studies for cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Cancer studiesPhase 2 Studies for Cancer
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
📍 University of San Francisco, California — San Francisco, California
View Study & Checklist ➔ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care
📍 University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
📍 Sunstone Medical, PC — Rockville, Maryland
View Study & Checklist ➔ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
📍 Cedars Sinai-The Angeles Clinic — Los Angeles, California
View Study & Checklist ➔Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔9-ING-41 in Patients With Advanced Cancers
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔Adaptive Radiotherapy for Safe Hypofractionation
📍 Centre Hospitalier de l'Université de Montréal — Montreal, Quebec
View Study & Checklist ➔Time Restricted Eating in Haematological Malignancies
📍 BC Cancer — Victoria, British Columbia
View Study & Checklist ➔Partner4Exercise Randomized Controlled Trial
📍 McMaster University — Hamilton, Ontario
View Study & Checklist ➔Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
📍 The University of Texas Medical Branch — Galveston, Texas
View Study & Checklist ➔FOG-001 in Locally Advanced or Metastatic Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Pan Tumor Rollover Study
📍 Local Institution - 0220 — Huntsville, Alabama
View Study & Checklist ➔Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Maitake for Integrative Cancer Care
📍 The Centre for Health Innovation — Ottawa, Ontario
View Study & Checklist ➔Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
📍 Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
View Study & Checklist ➔Acupuncture for People Experiencing Period Loss Due to Chemotherapy
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
📍 Markey Cancer Center, University of Kentucky — Lexington, Kentucky
View Study & Checklist ➔Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
📍 University of Cincinnati Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
📍 Cross Cancer Institute — Edmonton, Alberta
View Study & Checklist ➔MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
📍 Sunstone Medical, PC — Rockville, Maryland
View Study & Checklist ➔Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
📍 Stanford University Cancer Institute — Stanford, California
View Study & Checklist ➔Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
📍 UCLA Health — Los Angeles, California
View Study & Checklist ➔The IMPACT Implementation-Effectiveness Trial
📍 Joseph Brant Hospital — Burlington, Ontario
View Study & Checklist ➔Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
📍 NEXT Austin — Austin, Texas
View Study & Checklist ➔